MCRB · NASDAQ · Biotechnology

Seres Therapeutics (MCRB)

Develops oral bacterial consortia for infection, immune, and inflammatory conditions.

$5.54
Pre-market+0.03 (+0.54%)
At close$5.51(+6.37%)

Breakdown13F · 13D/G · Form 4

Institutions36 holders · as of Mar 31, 202623.82%2.31M shares
Insiders6 holders · as of Aug 18, 20260.49%47.8K shares
Strategic holders1 holder · as of Oct 2, 202411.30%1.09M shares
Otherremainder64.39%6.24M shares

9.68M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Flagship Pioneering Inc.Institution
11.94%1.16M13Fas of Mar 31, 2026
Nestle SAStrategic10 percent owner
11.30%1.09MForm 4filed Oct 2, 2024
Vanguard Capital Management LLCInstitution
3.04%294,14313Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
1.44%139,53913Fas of Mar 31, 2026
Vontobel Holding Ltd.Institution
1.43%138,46813Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution
1.09%105,33913Fas of Mar 31, 2026
BlackRock, Inc.Institution
1.05%102,02613Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.77%74,83513Fas of Mar 31, 2026
American Century Companies IncInstitution
0.64%62,31613Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.41%39,64313Fas of Mar 31, 2026
State Street CorpInstitution
0.35%33,90113Fas of Mar 31, 2026
Charles Schwab Investment Management IncInstitution
0.33%31,63013Fas of Mar 31, 2026
Lion Point Capital, LPInstitution
0.33%31,57013Fas of Mar 31, 2026
Morgan StanleyInstitution
0.22%21,70013Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution
0.19%18,79413Fas of Mar 31, 2026
Northern Trust CorpInstitution
0.15%14,76513Fas of Mar 31, 2026
Invesco Ltd.Institution
0.15%14,54713Fas of Mar 31, 2026
Eric D. ShaffInsiderdirector
0.13%12,499Form 4filed Aug 18, 2026
Kelly BradyInsiderofficer: See Remarks
0.09%8,679Form 4filed Aug 18, 2026
Teresa L. YoungInsiderofficer: See Remarks
0.09%8,557Form 4filed Feb 18, 2026
Thomas DesRosierInsiderofficer: See Remarks
0.08%8,117Form 4filed Aug 18, 2026
Matthew R. HennInsiderofficer: See Remarks
0.08%7,995Form 4filed Aug 18, 2026
UBS Group AGInstitution
0.07%7,03013Fas of Mar 31, 2026
Barclays PLCInstitution
0.07%6,50713Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.04%3,48213Fas of Mar 31, 2026

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

36 holders · 2.31M shares · 6 new positions · 16 increased · 8 reduced · 9 closed

HolderShares% outstandingChg q/qFiled
Flagship Pioneering Inc.1.16M11.94%0May 15, 2026
Vanguard Capital Management LLC294.1K3.04%+294.1KnewMay 15, 2026
Marshall Wace, LLP139.5K1.44%+19.4KMay 15, 2026
Vontobel Holding Ltd.138.5K1.43%+35.2KMay 8, 2026
Susquehanna International Group, LLP105.3K1.09%−74.6KMay 15, 2026
BlackRock, Inc.102.0K1.05%−1.6KMay 13, 2026
Geode Capital Management, LLC74.8K0.77%−11.3KMay 15, 2026
American Century Companies Inc62.3K0.64%+46.0KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
FMR LLC12.80%13GFeb 12, 2025

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 17, 2026
Kelly Bradyofficer: See Remarks
Sale64$4.558,679
Aug 17, 2026
Eric D. Shaffdirector
Sale263$4.5512,499
Aug 17, 2026
Thomas DesRosierofficer: See Remarks
Sale82$4.558,117
Aug 17, 2026
Matthew R. Hennofficer: See Remarks
Sale81$4.557,995
May 18, 2026
Matthew R. Hennofficer: See Remarks
Sale77$7.537,838
May 18, 2026
Kelly Bradyofficer: See Remarks
Sale59$7.538,562
May 18, 2026
Thomas DesRosierofficer: See Remarks
Sale79$7.537,954
May 18, 2026
Eric D. Shaffdirector
Sale259$7.5312,040
Feb 15, 2026
Matthew R. Hennofficer: See Remarks
Sale89$8.477,677
Feb 15, 2026
Thomas DesRosierofficer: See Remarks
Sale78$8.477,789

CongressHouse and Senate disclosures

Not reported.